Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
Br J Cancer. 2012 Jan 3;106(1):182-8. doi: 10.1038/bjc.2011.509. Epub 2011 Nov 22.
F-box and WD repeat domain-containing 7 (FBXW7) is a cell cycle regulatory gene whose protein product ubiquitinates positive cell cycle regulators such as c-Myc, cyclin E, and c-Jun, thereby acting as a tumour-suppressor gene. This study focused on microRNA-223 (miR-223), which is a candidate regulator of FBXW7 mRNA. The aim of this study was to clarify the clinical significance of miR-223 and FBXW7 in oesophageal squamous cell carcinoma (ESCC) patients, and to elucidate the mechanism by which FBXW7 is regulated by miR-223.
The expression levels of miR-223 and the expression of FBXW7 protein was examined using 109 resected specimens to determine the clinicopathological significance. We also investigated the role of miR-223 in the regulation of FBXW7 expression in ESCC cell lines in an in vitro analysis.
We found that miR-223 expression was significantly higher in cancerous tissues than in the corresponding normal tissues. There was a significant inverse relationship between the expression levels of miR-223 and FBXW7 protein. Moreover, patients with high miR-223 expression demonstrated a significantly poorer prognosis than those with low expression. On the basis of a series of gain-of-function and loss-of-function studies in vitro, we identified FBXW7 as a functional downstream target of miR-223.
Our present study indicates that high expression of miR-223 had a significant adverse impact on the survival of ESCC patients through repression of the function of FBXW7.
F-box 和 WD 重复结构域蛋白 7(FBXW7)是一种细胞周期调节基因,其蛋白产物可使 c-Myc、细胞周期蛋白 E 和 c-Jun 等阳性细胞周期调节剂泛素化,从而发挥肿瘤抑制基因的作用。本研究聚焦于 microRNA-223(miR-223),它是 FBXW7 mRNA 的候选调节因子。本研究旨在阐明 miR-223 和 FBXW7 在食管鳞状细胞癌(ESCC)患者中的临床意义,并阐明 miR-223 对 FBXW7 调节的机制。
使用 109 例切除标本检测 miR-223 的表达水平和 FBXW7 蛋白的表达,以确定其临床病理意义。我们还在体外分析中研究了 miR-223 在 ESCC 细胞系中调节 FBXW7 表达的作用。
我们发现癌组织中 miR-223 的表达明显高于相应的正常组织。miR-223 的表达水平与 FBXW7 蛋白的表达呈显著负相关。此外,miR-223 高表达的患者预后明显差于低表达的患者。基于一系列体外功能获得和功能丧失研究,我们确定 FBXW7 是 miR-223 的功能性下游靶标。
本研究表明,miR-223 的高表达通过抑制 FBXW7 的功能对 ESCC 患者的生存产生显著的不利影响。